NVP-LDE225, a Potent and Selective SMOOTHENED Antagonist Reduces Melanoma Growth In Vitro and In Vivo
Ahmad Jalili(Medical University of Vienna), Stephan N. Wagner(Medical University of Vienna)
Cited by 48
Related Papers
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
|Nature Communications|2019|374
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance
|Nature Communications|2017|141
MTSS1 is a metastasis driver in a subset of human melanomas
|Nature Communications|2014|63
Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells
|Cell Death and Disease|2016|23